|
1 Indications And Usage Noxafil Is An Azole Antifungal Agent Indicated For: Injection, Delayed-Release Tablets, And Oral Suspension Prophylaxis Of Invasive Aspergillus And Candida Infections In Patients Who Are At High Risk Of Developing These Infections Due To Being Severely Immunocompromised, Such As Hsct Recipients With Gvhd Or Those With Hematologic Malignancies With Prolonged Neutropenia From Chemotherapy. ( 1.1 ) Oral Suspension Treatment Of Oropharyngeal Candidiasis (Opc), Including Opc Refractory (Ropc) To Itraconazole And/or Fluconazole. ( 1.2 ) 1.1 Prophylaxis Of Invasive Aspergillus And Candida Infections Noxafil ® Injection, Delayed-Release Tablets, And Oral Suspension Are Indicated For Prophylaxis Of Invasive Aspergillus And Candida Infections In Patients Who Are At High Risk Of Developing These Infections Due To Being Severely Immunocompromised, Such As Hematopoietic Stem Cell Transplant (Hsct) Recipients With Graft-Versus-Host Disease (Gvhd) Or Those With Hematologic Malignancies With Prolonged Neutropenia From Chemotherapy. Noxafil Injection Is Indicated In Patients 18 Years Of Age And Older. Noxafil Delayed-Release Tablets And Oral Suspension Are Indicated In Patients 13 Years Of Age And Older. 1.2 Treatment Of Oropharyngeal Candidiasis Including Oropharyngeal Candidiasis Refractory To Itraconazole And/or Fluconazole Noxafil Oral Suspension Is Indicated For The Treatment Of Oropharyngeal Candidiasis, Including Oropharyngeal Candidiasis Refractory To Itraconazole And/or Fluconazole.
|